10x Genomics Inc - Ordinary Shares - Class A
NASDAQ:TXG 4:00:00 PM EDT
Market Cap (Intraday) | 4.47B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $37.42 |
50-Day MA | $42.75 |
200-Day MA | $47.17 |
10x Genomics Inc - Ordinary Shares - Class A Stock, NASDAQ:TXG
6230 Stoneridge Mall Road, Pleasanton, California 94588
United States of America
Phone: +1.925.401.7300
Number of Employees: 1259
Description
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company�s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.